Nonsteroidal Anti-Inflammatory Drugs: Exploiting Bivalent COXIB/ TP Antagonists for the Control of Cardiovascular Risk

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|24|30|3218-3230

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.24, Iss.30, 2017-10, pp. : 3218-3230

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Renal and cardiovascular toxicity of non-steroidal anti-inflammatory drugs

By McGettigan Patricia   Platona Adriana   Henry David A.  

Inflammopharmacology, Vol. 8, Iss. 1, 2000-03 ,pp. : 1-18

VSP

Access to resources Recommend Favorite

Comparative cardiovascular safety of traditional nonsteroidal anti-inflammatory drugs

By Maillard Marc   Burnier Michel  

Expert Opinion on Drug Safety, Vol. 5, Iss. 1, 2006-01 ,pp. : 83-94

Informa Healthcare

Access to resources Recommend Favorite

Risk:benefit ratio of nonsteroidal anti-inflammatory drugs in systemic lupus erythematosus

By Horizon Arash A   Wallace Daniel J  

Expert Opinion on Drug Safety, Vol. 3, Iss. 4, 2004-07 ,pp. : 273-278

Informa Healthcare

Access to resources Recommend Favorite

Relationship Between Nonsteroidal Anti-inflammatory Drugs and Fall Risk in Older Adults

By Findley L. Rebekah   Bulloch Marilyn N.  

The Consultant Pharmacist, Vol. 30, Iss. 6, 2015-06 ,pp. : 346-351

American Society of Consultant Pharmacists

Access to resources Recommend Favorite

Drug Interactions between Non-Steroidal Anti-Inflammatory Drugs and Cardiovascular Treatments (Except Anti-Agregant Therapy)

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 12, Iss. 1, 2013-03 ,pp. : 36-46

Bentham Science Publishers

Access to resources Recommend Favorite